Aspira Women's Health receives Nasdaq delisting notice for bid price below $1.00

Aspira Women's Health Inc.

Received Nasdaq notice on Oct 17, 2024 for non-compliance with minimum bid price ($1.00) for 30 consecutive business days.
Has 180 calendar days until April 15, 2025 to regain compliance by closing bid price at $1.00+ for 10 consecutive days.
If not compliant by April 15, may qualify for second 180-day period; else delisting with option to appeal.
Company will monitor and consider options to regain compliance; no assurance of maintaining listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.